Lemonade's downside risks are diminishing, and the potential for the company to thrive is increasing. Read why I remain ...

Up-and-coming insurance company Lemonade (NYSE: LMND) is trying to disrupt insurance by putting its spin on the industry.

Jason Hall has positions in Lemonade and has the following options: short November 2024 $39 calls on Lemonade. The Motley ...

Fintech stocks continued to post the largest gains among financials this past week as the crypto market continues to expect a ...

Lemonade stock price has gone parabolic, soaring for four consecutive weeks and reaching its highest level since December ...

In 2025, we can expect to see a convergence of several key trends that prioritize holistic health and personalized ...

BMO Capital raised the firm’s price target on Lemonade (LMND) to $15 from $13 and keeps an Underperform rating on the shares following ...

We’re all familiar with the concept of false advertising these days. But you might not always expect this behavior from a ...

Piper Sandler raised the firm’s price target on Lemonade (LMND) to $44 from $25 and keeps a Neutral rating on the shares after participating in the company’s well-attended investor day in New ...

That’s from the Al Copeland Foundation. You jump the line, get a t-shirt and a cup of Josh’s lemonade. And most of us all, ...

Morgan Stanley upgraded Lemonade (LMND) to Equal Weight from Underweight with a price target of $42, up from $23, following the investor day.